A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia
NCT07295951
Acute Leukemias, Acute Lymphoblastic Leukemia
Manchester, United Kingdom
View Trial DetailsNCT Number: NCT01439217
Specific Aim: Compare the endothelial function, arterial stiffness and components of metabolic syndrome of childhood Acute Lymphoblastic Leukemia (ALL) survivors to healthy sibling controls. Plan: A cross sectional study comparing ALL survivors to sibling controls including measures of endothelial function and arterial stiffness obtained form a peripheral artery tonometry device, height, weight, waist circumference, fasting lipid, glucose and insulin.
Looking for future studies?
Notify Me8 year–28 year
All sexes
Observational
Johns Hopkins Hospital, Baltimore, Maryland, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Survivor:
Inclusion
Inclusion
Exclusion criteria
Time frame: at enrollment
Looking for future studies?
Notify MeSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Other
Endothelial Function, Arterial Stiffness and Components of Metabolic Syndrome in Acute Lymphoblastic Leukemia (ALL) Survivors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07295951
Acute Leukemias, Acute Lymphoblastic Leukemia
Manchester, United Kingdom
View Trial DetailsNCT00435864
Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia
Nantes, France
View Trial DetailsNCT05969002
Acute Lymphoblastic Leukemia, B Cell
Bethesda, Maryland, United States
View Trial DetailsNCT01503632
Acute Lymphoblastic Leukemia, Hematologic Diseases
Birmingham, Alabama, United States
View Trial Details